TimothyPCripeMDPhD
Pediatric Hematology & Oncology • Columbus, OHProfessor, Pediatrics, Ohio State University College of Medicine
Dr. Cripe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
700 Childrens Dr
Columbus, OH 43205Phone+1 614-722-3552Fax+1 614-722-3699- Is this information wrong?
Education & Training
University of ColoradoFellowship, Pediatric Hematology/Oncology, 1993 - 1995
University of Iowa Hospitals and ClinicsResidency, Pediatrics, 1989 - 1992
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1989
Certifications & Licensure
OH State Medical License 1999 - 2025
CO State Medical License 1993 - 2009
WI State Medical License 1995 - 2001
IL State Medical License 1995 - 1999
IA State Medical License 1989 - 1994- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014-2020
Clinical Trials
- HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors Start of enrollment: 2010 Mar 01
- Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients Start of enrollment: 2010 Aug 01
- Ph1 Administration of VSV-IFNβ-NIS Monotherapy and in Combination With Avelumab in Pts With Refractory Solid Tumors Start of enrollment: 2017 Apr 17
Publications & Presentations
PubMed
- Reviving the lost art of meeting reports.Timothy P Cripe> ;Molecular Therapy. Oncology. 2024 Mar 21
- 1 citationsCancer gene therapy bears fruit.Timothy P Cripe> ;Molecular Therapy. 2023 Feb 1
- Myeloid cell heterogeneity in the tumor microenvironment and therapeutic implications for childhood central nervous system (CNS) tumors.Sujay Kalathoor, Sakthi Rajendran, Alessandro Canella, Raju Raval, Timothy P Cripe, Elaine R Mardis, Prajwal Rajappa> ;Journal of Neuroimmunology. 2023 Jan 15
- Join now to see all
Press Mentions
- TWiPO #93: CureWorks & Caring Cross: Pathways to Advance Cell & Gene Therapy with Dr. Rimas OrentasJanuary 20th, 2022
- Collaboration Between Rheumatologists, Primary Care Reduces Delay in Axial SpA DiagnosisAugust 4th, 2021
Shop TalkNovember 5th, 2019- Join now to see all
Grant Support
- Xenograft Core For NF1 Experimental TherapeuticsNational Institute Of Neurological Disorders And Stroke2010–2011
- Phase I Study Of Hsv1716 In Pediatric Non-Cns Solid Tumors,Ind 13196 12/04/2006Food And Drug Administration2010–2011
- Oncolytic HSV Therapy In Immunocompetent Sarcoma ModelsNational Cancer Institute2010
- Xenograft Core For NF1 Experimental TherapeuticsNational Institute Of Neurological Disorders And Stroke2008–2009
- Virotherapy For Neuroblastoma Stem CellsNational Cancer Institute2008–2009
- Oncolytic HSV Therapy In Immunocompetent Sarcoma ModelsNational Cancer Institute2006–2009
- Regulated Toxin Gene Therapy For RhabdomyosarcomaNational Cancer Institute1999–2001
- Regulated Toxin Gene Therapy For RhabdomyosarcomaNational Cancer Institute1997–1999
- HSC 70 And Agnoprotein In Papovavirus AssemblyNational Institute Of Allergy And Infectious Diseases1995–1997
Hospital Affiliations
Nationwide Children's HospitalColumbus, Ohio
Ohio State University Wexner Medical CenterColumbus, Ohio
The OSUCCC - JamesColumbus, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
